2nd Bioanalytic Sensors Conference May 5 - 6, 2015, Berlin, Germany

We invite you to the attend the 2nd Bioanalytic Sensors Conference, which will take place on May 5 - 6, 2015 in Berlin, Germany.

This premier conference will host an exciting group of professionals from the academic, biotech, pharmaceutical, and business communities, and will focus on the latest discoveries in the Bioanlytical Sensors field. A balance of both academic and industry experts will facilitate discussion on the following areas:

Sessions for the meeting include:
I. Advances in Sensor Development
II. Clinical Applications of Bioanalytical Sensors
III. Nano-material Enabled Sensing
IV. Disposable Sensors & Sensors for Low Resource Environments
V. Single Molecule Sensing
VI. In Vivo Sensing & Analysis
VII. Mass Spectometry and Immunosensing
VIII. Microfluidics

Please join us for the opportunity to listen to recent updates on research, share ideas with colleagues, and network with experts within the bioanalytical sensors field.

We hope to see you there!

2nd Tissue Models & Phenotypic Screening Conference May 5 - 7, 2015, Berlin, Germany

We invite you to the attend the 2nd Tissue Models & Phenotypic Screening Conference, which will take place on May 5 - 7, 2015 in Berlin, Germany.

Over the years, three-dimensional (3D) models have become more favored over two-dimensional models (2D) because they better mimic the in vivo environment. Though 3D models have the potential to reduce failure in early stage drug discovery, there are still many questions to be answered: What are the gaps that still exist between 3D and 2D models? How will we conduct research to fill those gaps and what technological developments are needed?

Sessions for the meeting include:
I. Human Tissue Engineered Models for Drug Development
II. Biomimetic In Vitro Models: Development, Structure, and Function
III. In-Vivo 3D Models for Drug Safety Testing (Toxicology) and Screening
IV. Phenotypic Screening with Functional Analysis Including Complex Models
V. Target Identification & Target Fishing After a Phenotypic Screen
VI. Phenotypic Screening for Target Deconvolution (joint session with parallel Drug Design & Medicinal Chemistry Conference)
VII. Advances in Phenotypic Screening and Functional Analysis
VIII. Case Studies in Phenotypic Screening
IX. High Content Analysis of Tumor Spheroid Models
X. Developing Physiologically Relevant Models: 2D, Tissue, and Organ System Models

This meeting will bring together researchers from across multiple disciplines, from both industry and academia, to discuss how we can better engineer tissues for clinical delivery and develop models for drug screening.

We hope to see you there!

9th Drug Design & Medicinal Chemistry Conference May 5-6, 2015, Berlin, Germany

We are excited to announce the 9th Drug Design & Medicinal Chemistry Conference, to be held May 5-6, 2015 in Berlin, Germany. This meeting will provide a multi-disciplinary forum for industry and academia colleagues to gather and explore the changing landscape in drug discovery: new ways of partnering, emerging target classes, and chemical biology approaches for discovering new medicines.

Leaders in the field will present on hot topics such as protein-protein interactions, phenotypic screening, allosteric inhibitors, and many more. Attendees will also have the opportunity to meet colleagues during dedicated networking sessions and form new connections.

European Pharma Summit May 5-8, 2015 Berlin, Germany

We invite you to the attend the European Pharma Summit, which will take place on May 5-8, 2015 in Berlin, Germany. This event seeks to create a forum for colleagues across multiple disciplines, as well as from both private and public sectors, to gather and exchange ideas. Over 400 delegates from pharmaceutical organization, biotech companies, and leading academic institutions will gather over the course of four days to listen to presentations on the hottest topics in drug discovery and network with both new and old colleagues.

The landscape for drug discovery has changed drastically over the past few years: private and public partnerships are changing how research is being done, researchers are using 3D model systems in hopes of improving clinical outcomes, and emerging target classes are changing traditional conceptions of the drug discovery process.

The Summit will feature six conferences that will cover the latest hot topics in drug discovery:

• 9th Drug Design & Medicinal Chemistry May 5-6
• 2nd Tissue Models & Drug Screening May 5-6
• Analytics for Biotheraputics & Bioanaylitcal Methods May 5-6
• 10th Protein Kinases in Drug Discovery May 7-8
• GPCR Targeted Screening May 7-8
• Phenotypic Screening May 7-8

2nd Bioanalytic Sensors Conference May 5 - 6, 2015, Berlin, Germany

We invite you to the attend the 2nd Bioanalytic Sensors Conference, which will take place on May 5 - 6, 2015 in Berlin, Germany.

This premier conference will host an exciting group of professionals from the academic, biotech, pharmaceutical, and business communities, and will focus on the latest discoveries in the Bioanlytical Sensors field. A balance of both academic and industry experts will facilitate discussion on the following areas:

Sessions for the meeting include:
I. Advances in Sensor Development
II. Clinical Applications of Bioanalytical Sensors
III. Nano-material Enabled Sensing
IV. Disposable Sensors & Sensors for Low Resource Environments
V. Single Molecule Sensing
VI. In Vivo Sensing & Analysis
VII. Mass Spectometry and Immunosensing
VIII. Microfluidics

Please join us for the opportunity to listen to recent updates on research, share ideas with colleagues, and network with experts within the bioanalytical sensors field.

We hope to see you there!

2nd Tissue Models & Phenotypic Screening Conference May 5 - 7, 2015, Berlin, Germany

We invite you to the attend the 2nd Tissue Models & Phenotypic Screening Conference, which will take place on May 5 - 7, 2015 in Berlin, Germany.

Over the years, three-dimensional (3D) models have become more favored over two-dimensional models (2D) because they better mimic the in vivo environment. Though 3D models have the potential to reduce failure in early stage drug discovery, there are still many questions to be answered: What are the gaps that still exist between 3D and 2D models? How will we conduct research to fill those gaps and what technological developments are needed?

Sessions for the meeting include:
I. Human Tissue Engineered Models for Drug Development
II. Biomimetic In Vitro Models: Development, Structure, and Function
III. In-Vivo 3D Models for Drug Safety Testing (Toxicology) and Screening
IV. Phenotypic Screening with Functional Analysis Including Complex Models
V. Target Identification & Target Fishing After a Phenotypic Screen
VI. Phenotypic Screening for Target Deconvolution (joint session with parallel Drug Design & Medicinal Chemistry Conference)
VII. Advances in Phenotypic Screening and Functional Analysis
VIII. Case Studies in Phenotypic Screening
IX. High Content Analysis of Tumor Spheroid Models
X. Developing Physiologically Relevant Models: 2D, Tissue, and Organ System Models

This meeting will bring together researchers from across multiple disciplines, from both industry and academia, to discuss how we can better engineer tissues for clinical delivery and develop models for drug screening.

We hope to see you there!

9th Drug Design & Medicinal Chemistry Conference May 5-6, 2015, Berlin, Germany

We are excited to announce the 9th Drug Design & Medicinal Chemistry Conference, to be held May 5-6, 2015 in Berlin, Germany. This meeting will provide a multi-disciplinary forum for industry and academia colleagues to gather and explore the changing landscape in drug discovery: new ways of partnering, emerging target classes, and chemical biology approaches for discovering new medicines.

Leaders in the field will present on hot topics such as protein-protein interactions, phenotypic screening, allosteric inhibitors, and many more. Attendees will also have the opportunity to meet colleagues during dedicated networking sessions and form new connections.

European Pharma Summit May 5-8, 2015 Berlin, Germany

We invite you to the attend the European Pharma Summit, which will take place on May 5-8, 2015 in Berlin, Germany. This event seeks to create a forum for colleagues across multiple disciplines, as well as from both private and public sectors, to gather and exchange ideas. Over 400 delegates from pharmaceutical organization, biotech companies, and leading academic institutions will gather over the course of four days to listen to presentations on the hottest topics in drug discovery and network with both new and old colleagues.

The landscape for drug discovery has changed drastically over the past few years: private and public partnerships are changing how research is being done, researchers are using 3D model systems in hopes of improving clinical outcomes, and emerging target classes are changing traditional conceptions of the drug discovery process.

The Summit will feature six conferences that will cover the latest hot topics in drug discovery:

• 9th Drug Design & Medicinal Chemistry May 5-6
• 2nd Tissue Models & Drug Screening May 5-6
• Analytics for Biotheraputics & Bioanaylitcal Methods May 5-6
• 10th Protein Kinases in Drug Discovery May 7-8
• GPCR Targeted Screening May 7-8
• Phenotypic Screening May 7-8

2nd Tissue Models & Phenotypic Screening Conference May 5 - 7, 2015, Berlin, Germany

We invite you to the attend the 2nd Tissue Models & Phenotypic Screening Conference, which will take place on May 5 - 7, 2015 in Berlin, Germany.

Over the years, three-dimensional (3D) models have become more favored over two-dimensional models (2D) because they better mimic the in vivo environment. Though 3D models have the potential to reduce failure in early stage drug discovery, there are still many questions to be answered: What are the gaps that still exist between 3D and 2D models? How will we conduct research to fill those gaps and what technological developments are needed?

Sessions for the meeting include:
I. Human Tissue Engineered Models for Drug Development
II. Biomimetic In Vitro Models: Development, Structure, and Function
III. In-Vivo 3D Models for Drug Safety Testing (Toxicology) and Screening
IV. Phenotypic Screening with Functional Analysis Including Complex Models
V. Target Identification & Target Fishing After a Phenotypic Screen
VI. Phenotypic Screening for Target Deconvolution (joint session with parallel Drug Design & Medicinal Chemistry Conference)
VII. Advances in Phenotypic Screening and Functional Analysis
VIII. Case Studies in Phenotypic Screening
IX. High Content Analysis of Tumor Spheroid Models
X. Developing Physiologically Relevant Models: 2D, Tissue, and Organ System Models

This meeting will bring together researchers from across multiple disciplines, from both industry and academia, to discuss how we can better engineer tissues for clinical delivery and develop models for drug screening.

We hope to see you there!

European Pharma Summit May 5-8, 2015 Berlin, Germany

We invite you to the attend the European Pharma Summit, which will take place on May 5-8, 2015 in Berlin, Germany. This event seeks to create a forum for colleagues across multiple disciplines, as well as from both private and public sectors, to gather and exchange ideas. Over 400 delegates from pharmaceutical organization, biotech companies, and leading academic institutions will gather over the course of four days to listen to presentations on the hottest topics in drug discovery and network with both new and old colleagues.

The landscape for drug discovery has changed drastically over the past few years: private and public partnerships are changing how research is being done, researchers are using 3D model systems in hopes of improving clinical outcomes, and emerging target classes are changing traditional conceptions of the drug discovery process.

The Summit will feature six conferences that will cover the latest hot topics in drug discovery:

• 9th Drug Design & Medicinal Chemistry May 5-6
• 2nd Tissue Models & Drug Screening May 5-6
• Analytics for Biotheraputics & Bioanaylitcal Methods May 5-6
• 10th Protein Kinases in Drug Discovery May 7-8
• GPCR Targeted Screening May 7-8
• Phenotypic Screening May 7-8

10th Protein Kinases in Drug Discovery Conference May 7-8, 2015, Berlin, Germany

We invite you to the attend the 10th Protein Kinases in Drug Discovery Conference, which will take place on May 7-8, 2015 in Berlin, Germany.

 Over the past decades, protein kinases have proven to be an important class of drug targets for the pharmaceutical industry. This meeting seeks to create a forum for scientists from both industry and academia to gather and discuss the most recent advances in kinase inhibitor research. Leading researchers will present on hot topics such as irreversible inhibitors, allosteric inhibitors, and many more. In addition to scientific talks, dedicated networking sessions will allow attendees to better dialogue on how kinase inhibitor discovery will continue to expand beyond oncology into applications in CNS disorders, inflammation, and more.

GPCR Targeted Screening Conference May 7 - 8, 2015, Berlin, Germany

We invite you to the attend the 2nd GPCR Targeted Screening Conference, which will take place on May 7 - 8, 2015 in Berlin, Germany.

Sessions for the meeting include:

I. Allosteric Modulators & Biased Signaling
II. GPCR Dynamics, Signaling, Structure, and Mechanisms
- Membrane Protein Structures
- Computational Modeling and Structural Dynamics of GPCRs
III. GPCRs in Disease
IV. In Silico Screening
V. GPCR Chemical Biology & Novel Molecular Probes

We hope to see you there!

MEDEXPO AFRICA - KENYA 2015 on 07 - 09 May, 2015 in Nairobi, Kenya

Strong exhibitor line-up from over 15 countries and a comprehensive medical product, equipment & machinery showcase at Kenya's biggest International Medical Trade Exhibition.

The increasing demand for medical manufacturing products, equipment, machinery, services and solutions has prompted a surge of representation at Africa's premier medical exhibition, MEDEXPO AFRICA - KENYA 2015. Taking place at The Kenyatta International Conference Center, Nairobi , Kenya, from the 07 - 09 May, 2015, the exhibition profile innovative solutions from leading market players for the benefit of medical technology buyers from across the East African region. Targeted buyers from across the East Africa are seeking new products, equipment, machinery, services and solutions to keep abreast of industry trends and developments.

According to medical professionals in the region: "It will be the most important and relevant trade exhibition for industry professionals in the medical field to source for products, meet new business contacts, build partnerships, and keep abreast of industry trends and developments." Kenya is currently the largest producer of pharmaceutical products in the Common Market for Eastern and Southern Africa (COMESA) region, supplying about 50% of the regions' market. Out of the region's estimated of 50 recognized pharmaceutical manufacturers; approximately 30 are based in Kenya.

Due to an aggressive campaign, the number of exhibitor's registration has risen by at least 20% as compared to last year. Visitor inquiries & registration is very strong and a forecast in the increase in the visitors flow to a 25% rise for the event. MEDEXPO AFRICA - KENYA 2015 aims to raise the medical industry standards, by connecting market players such as manufacturers, suppliers, systems partners, researchers, engineers and technical buyers. Trade visitors from all over East & Central African countries are being invited directly and in collaboration with several regional trade bodies in Kenya, Tanzania, Ethiopia, Uganda, Somalia, Mozambique & Congo.

Every year, MEDEXPO attracts a huge number of radical medical equipment manufacturing & distribution companies to showcase their medical technologies, products and services. Both exhibitors & visitors receive the personalized attention in the show, hence making the MEDEXPO Africa eminent!

European Pharma Summit May 5-8, 2015 Berlin, Germany

We invite you to the attend the European Pharma Summit, which will take place on May 5-8, 2015 in Berlin, Germany. This event seeks to create a forum for colleagues across multiple disciplines, as well as from both private and public sectors, to gather and exchange ideas. Over 400 delegates from pharmaceutical organization, biotech companies, and leading academic institutions will gather over the course of four days to listen to presentations on the hottest topics in drug discovery and network with both new and old colleagues.

The landscape for drug discovery has changed drastically over the past few years: private and public partnerships are changing how research is being done, researchers are using 3D model systems in hopes of improving clinical outcomes, and emerging target classes are changing traditional conceptions of the drug discovery process.

The Summit will feature six conferences that will cover the latest hot topics in drug discovery:

• 9th Drug Design & Medicinal Chemistry May 5-6
• 2nd Tissue Models & Drug Screening May 5-6
• Analytics for Biotheraputics & Bioanaylitcal Methods May 5-6
• 10th Protein Kinases in Drug Discovery May 7-8
• GPCR Targeted Screening May 7-8
• Phenotypic Screening May 7-8

10th Protein Kinases in Drug Discovery Conference May 7-8, 2015, Berlin, Germany

We invite you to the attend the 10th Protein Kinases in Drug Discovery Conference, which will take place on May 7-8, 2015 in Berlin, Germany.

 Over the past decades, protein kinases have proven to be an important class of drug targets for the pharmaceutical industry. This meeting seeks to create a forum for scientists from both industry and academia to gather and discuss the most recent advances in kinase inhibitor research. Leading researchers will present on hot topics such as irreversible inhibitors, allosteric inhibitors, and many more. In addition to scientific talks, dedicated networking sessions will allow attendees to better dialogue on how kinase inhibitor discovery will continue to expand beyond oncology into applications in CNS disorders, inflammation, and more.

GPCR Targeted Screening Conference May 7 - 8, 2015, Berlin, Germany

We invite you to the attend the 2nd GPCR Targeted Screening Conference, which will take place on May 7 - 8, 2015 in Berlin, Germany.

Sessions for the meeting include:

I. Allosteric Modulators & Biased Signaling
II. GPCR Dynamics, Signaling, Structure, and Mechanisms
- Membrane Protein Structures
- Computational Modeling and Structural Dynamics of GPCRs
III. GPCRs in Disease
IV. In Silico Screening
V. GPCR Chemical Biology & Novel Molecular Probes

We hope to see you there!

MEDEXPO AFRICA - KENYA 2015 on 07 - 09 May, 2015 in Nairobi, Kenya

Strong exhibitor line-up from over 15 countries and a comprehensive medical product, equipment & machinery showcase at Kenya's biggest International Medical Trade Exhibition.

The increasing demand for medical manufacturing products, equipment, machinery, services and solutions has prompted a surge of representation at Africa's premier medical exhibition, MEDEXPO AFRICA - KENYA 2015. Taking place at The Kenyatta International Conference Center, Nairobi , Kenya, from the 07 - 09 May, 2015, the exhibition profile innovative solutions from leading market players for the benefit of medical technology buyers from across the East African region. Targeted buyers from across the East Africa are seeking new products, equipment, machinery, services and solutions to keep abreast of industry trends and developments.

According to medical professionals in the region: "It will be the most important and relevant trade exhibition for industry professionals in the medical field to source for products, meet new business contacts, build partnerships, and keep abreast of industry trends and developments." Kenya is currently the largest producer of pharmaceutical products in the Common Market for Eastern and Southern Africa (COMESA) region, supplying about 50% of the regions' market. Out of the region's estimated of 50 recognized pharmaceutical manufacturers; approximately 30 are based in Kenya.

Due to an aggressive campaign, the number of exhibitor's registration has risen by at least 20% as compared to last year. Visitor inquiries & registration is very strong and a forecast in the increase in the visitors flow to a 25% rise for the event. MEDEXPO AFRICA - KENYA 2015 aims to raise the medical industry standards, by connecting market players such as manufacturers, suppliers, systems partners, researchers, engineers and technical buyers. Trade visitors from all over East & Central African countries are being invited directly and in collaboration with several regional trade bodies in Kenya, Tanzania, Ethiopia, Uganda, Somalia, Mozambique & Congo.

Every year, MEDEXPO attracts a huge number of radical medical equipment manufacturing & distribution companies to showcase their medical technologies, products and services. Both exhibitors & visitors receive the personalized attention in the show, hence making the MEDEXPO Africa eminent!

MEDEXPO AFRICA - KENYA 2015 on 07 - 09 May, 2015 in Nairobi, Kenya

Strong exhibitor line-up from over 15 countries and a comprehensive medical product, equipment & machinery showcase at Kenya's biggest International Medical Trade Exhibition.

The increasing demand for medical manufacturing products, equipment, machinery, services and solutions has prompted a surge of representation at Africa's premier medical exhibition, MEDEXPO AFRICA - KENYA 2015. Taking place at The Kenyatta International Conference Center, Nairobi , Kenya, from the 07 - 09 May, 2015, the exhibition profile innovative solutions from leading market players for the benefit of medical technology buyers from across the East African region. Targeted buyers from across the East Africa are seeking new products, equipment, machinery, services and solutions to keep abreast of industry trends and developments.

According to medical professionals in the region: "It will be the most important and relevant trade exhibition for industry professionals in the medical field to source for products, meet new business contacts, build partnerships, and keep abreast of industry trends and developments." Kenya is currently the largest producer of pharmaceutical products in the Common Market for Eastern and Southern Africa (COMESA) region, supplying about 50% of the regions' market. Out of the region's estimated of 50 recognized pharmaceutical manufacturers; approximately 30 are based in Kenya.

Due to an aggressive campaign, the number of exhibitor's registration has risen by at least 20% as compared to last year. Visitor inquiries & registration is very strong and a forecast in the increase in the visitors flow to a 25% rise for the event. MEDEXPO AFRICA - KENYA 2015 aims to raise the medical industry standards, by connecting market players such as manufacturers, suppliers, systems partners, researchers, engineers and technical buyers. Trade visitors from all over East & Central African countries are being invited directly and in collaboration with several regional trade bodies in Kenya, Tanzania, Ethiopia, Uganda, Somalia, Mozambique & Congo.

Every year, MEDEXPO attracts a huge number of radical medical equipment manufacturing & distribution companies to showcase their medical technologies, products and services. Both exhibitors & visitors receive the personalized attention in the show, hence making the MEDEXPO Africa eminent!

Pharmacovigilance, Drug Safety & Risk Management 11-12 May 2015, London UK

The expansive field of drug surveillance has increased the complexity of problems across the board in relation to PV auditing and meeting the standard requirements. Companies continue to face challenges of understanding the key considerations when presenting to auditors and knowing how to adequately adapt to different regulatory environments and changes. Moreover, clarifying individual roles within the PV system is paramount to setting out clear goals and meeting regulatory expectations.

For any company looking to globalise their business, the governance of reporting adverse drug events by different centralised authorities, along with heterogeneous terminologies and competing priorities has created greater uncertainties and barriers to enter new markets. The daunting task of complying with multiple regulations also heightens the danger of unrealistic expectations as well as mounting costs and time that will have long-term implications on investment.
Therefore, the importance of a centralised database has never been more vital to employ knowledge sharing and product awareness.

Join SMi in tackling these issues: 2015 will bring a focus on drug surveillance and signal detection; analysis and prevention of adverse drug reactions with MedDRA, industry experiences and global regulatory coverage of developments. Furthermore, we will cover Eudravigilance, and the growing trend of outsourcing Pharmacovigilance, as well as navigate through the challenges of compiling PSUR’s and frequent safety reports and how to adapt better to regulatory updates by preparing key areas that will be most impacted.

Pharmacovigilance, Drug Safety & Risk Management 11-12 May 2015, London UK

The expansive field of drug surveillance has increased the complexity of problems across the board in relation to PV auditing and meeting the standard requirements. Companies continue to face challenges of understanding the key considerations when presenting to auditors and knowing how to adequately adapt to different regulatory environments and changes. Moreover, clarifying individual roles within the PV system is paramount to setting out clear goals and meeting regulatory expectations.

For any company looking to globalise their business, the governance of reporting adverse drug events by different centralised authorities, along with heterogeneous terminologies and competing priorities has created greater uncertainties and barriers to enter new markets. The daunting task of complying with multiple regulations also heightens the danger of unrealistic expectations as well as mounting costs and time that will have long-term implications on investment.
Therefore, the importance of a centralised database has never been more vital to employ knowledge sharing and product awareness.

Join SMi in tackling these issues: 2015 will bring a focus on drug surveillance and signal detection; analysis and prevention of adverse drug reactions with MedDRA, industry experiences and global regulatory coverage of developments. Furthermore, we will cover Eudravigilance, and the growing trend of outsourcing Pharmacovigilance, as well as navigate through the challenges of compiling PSUR’s and frequent safety reports and how to adapt better to regulatory updates by preparing key areas that will be most impacted.

Academic Drug Discovery, 19-20 May, Cambridge, UK

SELECTBIO’s Academic Drug Discovery 2015, Cambridge, UK, will be a progression from our successful academic discovery events in the USA. Creating a European platform to bridge the gap between basic research and commercial application for innovative technologies. With talks from global experts on partnering models between both industrial and academic organizations that have successfully contributed to modern medical interventions.

Keynote Speakers:
- Stephen Frye
Director of The Center for Integrative Chemical Biology and Drug Discovery, University of North Carolina
- Marcie Glicksman
Co-Director, Harvard NeuroDiscovery Center and Brigham and Women's Hospital

Agenda Topics:

•    Drug discovery technology transfer
•    European lead generation and enabling open innovation
•    Novel approaches across different therapeutic areas
•    Partnering models for academia and industry
•    Professional translational research

The agenda is available to view online.

Academic Drug Discovery, 19-20 May, Cambridge, UK

SELECTBIO’s Academic Drug Discovery 2015, Cambridge, UK, will be a progression from our successful academic discovery events in the USA. Creating a European platform to bridge the gap between basic research and commercial application for innovative technologies. With talks from global experts on partnering models between both industrial and academic organizations that have successfully contributed to modern medical interventions.

Keynote Speakers:
- Stephen Frye
Director of The Center for Integrative Chemical Biology and Drug Discovery, University of North Carolina
- Marcie Glicksman
Co-Director, Harvard NeuroDiscovery Center and Brigham and Women's Hospital

Agenda Topics:

•    Drug discovery technology transfer
•    European lead generation and enabling open innovation
•    Novel approaches across different therapeutic areas
•    Partnering models for academia and industry
•    Professional translational research

The agenda is available to view online.

5th Next Generation Sequencing Conference May 21-22, 2015, Boston, MA

We invite you to the attend the 5th Next Generation Sequencing Conference, which will be part of the Pan-Omics Summit to be held May 21 - 22, 2015 in Boston, MA at the Hyatt Regency. This conference aims to gather both industry and academia for a rich exchange of networking and updates in this field.

The 5th Next Generation Sequencing Conference will provide attendees with a better understanding of developments in new next generation sequencing technologies alongside clinical applications. Some key areas of research include nanopore sequencing, sequencing by tunneling, single cell RNA sequencing, all electron sequencing, and data integration.

Conference date: May 21-22, 2015
Venue: Hyatt Regency, Boston, MA

Epigenomics & Novel Therapeutic Targets Conference May 21-22, 2015, Boston, MA

On behalf of GTCbio and the 2015 Advisory Board, you are invited the Epigenomics & Novel Therapeutic Targets Conference which takes place May 21-22, 2015 in Boston, MA. This meeting is part of The Pan-Omics Summit and focuses on transcriptional regulation, novel therapeutic targets and discoveries, pre-clinical to clinical drug development, new technological advances, and epigenomic biomarkers and diagnostics.

Epigenomics is still a growing field and young in comparison to its counterparts. Investigators are facing many challenges in terms of immunotherapeutic research and instrumental analysis. This conference is for the scientists, researchers, laboratory leaders, and managers who are working in the field and allows these experts to share their findings and techniques in order to bridge technological and computational gaps that affect datasets, interpretation, and the clinical applications of epigenomics.

Session topics include:
I. Transcriptional Regulation
II. Novel Therapeutic Targets and Discovery
III. Pre-Clinical to Clinical Drug Development
IV. New Technological Advances
V. Epigenomic Biomarkers and Diagnostics
VI. Neurological Disorders and Other Diseases

Functional Genomics Conference May 21-22, 2015, Boston, MA

The Functional Genomics Conference, a part of The Pan-Omics Summit, will be held on May 21 - 22, 2015 in Boston, MA at the Hyatt Regency.

The Functional Genomics Conference focuses on understanding the specific cellular events that occur on every level of transcription, translation, and protein-protein interactions. Speakers will present on mutations that are controlled at the level of DNA and how they are predictors for the change in function and structure in downstream products. Recent developments in gene targeting technology provides crucial information in target validation for therapeutics and application in the areas of inflammation, oncology, immunology, and infectious diseases. Also, we will take a closer look at genomic variation in relation to predicting a patient's response to drugs.

Topics to be discussed:

I. Genomic Variation as a Predictor of Protein-protein and Protein Drug Interactions
II. Molecular Diagnostics and Therapeutic Application for Complex Diseases
III.Transcriptome Profiling and Genome Regulation by mRNAs, microRNAs, and long noncoding RNAs
IV. Approaches for Analysis and Intergration of Complex Data
V. Genome Wide Mutagenesis and Phenotypic Analysis
VI. Developments and Challenges in Target Validation
VII. Prospects for Epigenomic-based Drug Discovery

Pan Omics Summit May 21-22,2015 Boston, MA

We invite you to the attend the Pan-Omics Summit, which will take place May 21 - 22, 2015 in Boston, MA at the Hyatt Regency. This summit has four parallel tracks to discuss the developments and challenges in the popular omics areas of epigenomics, metabolomics, functional genomics, and next generation sequencing. Representatives from big pharma, academic institutions, and government research labs will present data on advances in new technology and case studies on therapeutic targets, molecular diagnostics, and integration of complex data.

The Pan-Omics Summit is comprised of 4 parallel conferences:

5th Next Generation Sequencing

I. Current and Emerging Sequencing Technologies
II. Metagenomics and the Microbiome
III. Leveraging Big Data for Biomedical Discoveries and Applications
IV. Clinical Diagnostic Sequencing
V. RNA Sequencing
VI. Single Cell Genomics
VII. How Information and Technology get into the Clinic

2nd Metabolomics-Advances & Applications in Human Disease

I. Advances in Metabolite Markers
II. Metabolite Identification - Targets and Pathways
III. Computational Approaches to Assessing the Metabolome
IV. Technological Advances in Metabolomics
V. Clinical Applications of Metabolomics

Epigenomics & Novel Therapeutic Targets

I. Transcriptional Regulation
II. Novel Therapeutic Targets and Discovery
III. Pre-Clinical to Clinical Drug Development
IV. New Technological Advances
V. Epigenomic Biomarkers and Diagnostics 
VI. Neurological Disorders and Other Diseases

Functional Genomics

I. Genomic Variation as a Predictor of Protein-protein and Protein Drug Interactions
II. Molecular Diagnostics & Therapeutic Applications for Complex Diseases
III. Transcriptome Profiling and Genome Regulation by mRNAs, microRNAs and long noncoding RNAs
IV. Approaches for Analysis and Integration of Complex Data
V. Genome Wide Mutagenesis and Phenotypic Analysis
VI. Challenges in Target Validation
VII. Prospects for Epigenomic-based Drug Discovery

2nd Metabolomics - Advances & Applications in Human Disease Conference May 21-22, 2015, Boston, MA

GTCbio is proud to present the 2nd Metabolomics - Advances & Applications in Human Disease Conference, which will be part of The Pan-Omics Summit and takes place May 21-22, 2015 in Boston, MA.

There is still significant human variability in metabolite identification for targets and pathways. These challenges affect the advancement in metabolomics, the use of biomarkers, and its application towards cancer, metabolic disorders, and neurodegenerative diseases. Join us for an event that presents new research and offers networking opportunities with the researchers and scientists who are working on developing clinical assays, connecting the metabolome and the genome, and establishing common quality standards for experimental data.

Sessions:
I. Advances in Metabolite Markers
II. Metabolite Identification - Targets and Pathways
III. Computational Approaches to Assessing the Metabolome
IV. Technological Advances in Metabolomics
Panel:
I. Clinical Applications of Metabolomics

5th Next Generation Sequencing Conference May 21-22, 2015, Boston, MA

We invite you to the attend the 5th Next Generation Sequencing Conference, which will be part of the Pan-Omics Summit to be held May 21 - 22, 2015 in Boston, MA at the Hyatt Regency. This conference aims to gather both industry and academia for a rich exchange of networking and updates in this field.

The 5th Next Generation Sequencing Conference will provide attendees with a better understanding of developments in new next generation sequencing technologies alongside clinical applications. Some key areas of research include nanopore sequencing, sequencing by tunneling, single cell RNA sequencing, all electron sequencing, and data integration.

Conference date: May 21-22, 2015
Venue: Hyatt Regency, Boston, MA

Epigenomics & Novel Therapeutic Targets Conference May 21-22, 2015, Boston, MA

On behalf of GTCbio and the 2015 Advisory Board, you are invited the Epigenomics & Novel Therapeutic Targets Conference which takes place May 21-22, 2015 in Boston, MA. This meeting is part of The Pan-Omics Summit and focuses on transcriptional regulation, novel therapeutic targets and discoveries, pre-clinical to clinical drug development, new technological advances, and epigenomic biomarkers and diagnostics.

Epigenomics is still a growing field and young in comparison to its counterparts. Investigators are facing many challenges in terms of immunotherapeutic research and instrumental analysis. This conference is for the scientists, researchers, laboratory leaders, and managers who are working in the field and allows these experts to share their findings and techniques in order to bridge technological and computational gaps that affect datasets, interpretation, and the clinical applications of epigenomics.

Session topics include:
I. Transcriptional Regulation
II. Novel Therapeutic Targets and Discovery
III. Pre-Clinical to Clinical Drug Development
IV. New Technological Advances
V. Epigenomic Biomarkers and Diagnostics
VI. Neurological Disorders and Other Diseases

Functional Genomics Conference May 21-22, 2015, Boston, MA

The Functional Genomics Conference, a part of The Pan-Omics Summit, will be held on May 21 - 22, 2015 in Boston, MA at the Hyatt Regency.

The Functional Genomics Conference focuses on understanding the specific cellular events that occur on every level of transcription, translation, and protein-protein interactions. Speakers will present on mutations that are controlled at the level of DNA and how they are predictors for the change in function and structure in downstream products. Recent developments in gene targeting technology provides crucial information in target validation for therapeutics and application in the areas of inflammation, oncology, immunology, and infectious diseases. Also, we will take a closer look at genomic variation in relation to predicting a patient's response to drugs.

Topics to be discussed:

I. Genomic Variation as a Predictor of Protein-protein and Protein Drug Interactions
II. Molecular Diagnostics and Therapeutic Application for Complex Diseases
III.Transcriptome Profiling and Genome Regulation by mRNAs, microRNAs, and long noncoding RNAs
IV. Approaches for Analysis and Intergration of Complex Data
V. Genome Wide Mutagenesis and Phenotypic Analysis
VI. Developments and Challenges in Target Validation
VII. Prospects for Epigenomic-based Drug Discovery

Pan Omics Summit May 21-22,2015 Boston, MA

We invite you to the attend the Pan-Omics Summit, which will take place May 21 - 22, 2015 in Boston, MA at the Hyatt Regency. This summit has four parallel tracks to discuss the developments and challenges in the popular omics areas of epigenomics, metabolomics, functional genomics, and next generation sequencing. Representatives from big pharma, academic institutions, and government research labs will present data on advances in new technology and case studies on therapeutic targets, molecular diagnostics, and integration of complex data.

The Pan-Omics Summit is comprised of 4 parallel conferences:

5th Next Generation Sequencing

I. Current and Emerging Sequencing Technologies
II. Metagenomics and the Microbiome
III. Leveraging Big Data for Biomedical Discoveries and Applications
IV. Clinical Diagnostic Sequencing
V. RNA Sequencing
VI. Single Cell Genomics
VII. How Information and Technology get into the Clinic

2nd Metabolomics-Advances & Applications in Human Disease

I. Advances in Metabolite Markers
II. Metabolite Identification - Targets and Pathways
III. Computational Approaches to Assessing the Metabolome
IV. Technological Advances in Metabolomics
V. Clinical Applications of Metabolomics

Epigenomics & Novel Therapeutic Targets

I. Transcriptional Regulation
II. Novel Therapeutic Targets and Discovery
III. Pre-Clinical to Clinical Drug Development
IV. New Technological Advances
V. Epigenomic Biomarkers and Diagnostics 
VI. Neurological Disorders and Other Diseases

Functional Genomics

I. Genomic Variation as a Predictor of Protein-protein and Protein Drug Interactions
II. Molecular Diagnostics & Therapeutic Applications for Complex Diseases
III. Transcriptome Profiling and Genome Regulation by mRNAs, microRNAs and long noncoding RNAs
IV. Approaches for Analysis and Integration of Complex Data
V. Genome Wide Mutagenesis and Phenotypic Analysis
VI. Challenges in Target Validation
VII. Prospects for Epigenomic-based Drug Discovery

2nd Metabolomics - Advances & Applications in Human Disease Conference May 21-22, 2015, Boston, MA

GTCbio is proud to present the 2nd Metabolomics - Advances & Applications in Human Disease Conference, which will be part of The Pan-Omics Summit and takes place May 21-22, 2015 in Boston, MA.

There is still significant human variability in metabolite identification for targets and pathways. These challenges affect the advancement in metabolomics, the use of biomarkers, and its application towards cancer, metabolic disorders, and neurodegenerative diseases. Join us for an event that presents new research and offers networking opportunities with the researchers and scientists who are working on developing clinical assays, connecting the metabolome and the genome, and establishing common quality standards for experimental data.

Sessions:
I. Advances in Metabolite Markers
II. Metabolite Identification - Targets and Pathways
III. Computational Approaches to Assessing the Metabolome
IV. Technological Advances in Metabolomics
Panel:
I. Clinical Applications of Metabolomics